-
Prostate Cancer Screening; Can We Trust Home BP Measurement?; Systolic and Diastolic Dysfunction
-
The excess risk of Achilles tendon disorders attributable to fluoroquinolone use was estimated to be 3.2 cases per 1000 patient-years, with most of that increase accounted for by patients 60 years of age and older who concomitantly receive corticosteroids.
-
SSRIs increase the risk of upper gastrointestinal bleeding, and this effect is potentiated by concomitant NSAID or aspirin use.
-
The following summaries represent a selection of papers from among those presented at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), held September 27-30, 2002, in San Diego and the 40th annual meeting of the Infectious Disease Society of America (IDSA), held October 24-27, 2002, in Chicago. Antiretroviral therapy is not included.
-
FDA Issues Black Box Warning Based on WHI Study; ALLHAT: Thiazide for Hypertension Treatment; Candesartan Effective Against Migraines; Cough! No Cold Relief from Echinacea; COX-2 Inhibitors and GI Benefits Could Be Overrated; FDA Actions
-
Stroke Reduction in Older Hypertensives with Abnormal Nocturnal Blood
Pressure Dipping; Primary Prevention of Hypertension; Effect of
Aggressive Screening and Treatment on Prostate Cancer Mortality;
Diuretics, Mortality, and Nonrecovery of Renal Function in Acute Renal
Failure; Nut and Peanut Butter Consumption and Risk of DM-2 in Women;
Optimal Diets for Prevention of CHD
-
-
-
The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-Aged Men; Effects of Amlodipine Fosinopril Combination on Microalbuminuria in Hypertensive Type 2 Diabetic Patients; Relation Between Alcohol Consumption and C-Reactive Protein Levels in the Adult United States Population
-
In this review of outcomes from cardiopulmonary resuscitation among non-ICU inpatients in 3 urban teaching hospitals, no patient who had an unwitnessed cardiac arrest survived to discharge. Forty-four percent of patients with witnessed respiratory arrest returned to their homes, as compared with 13% of patients with witnessed cardiac arrest (21% for pulseless ventricular tachycardia or fibrillation, and 7% for pulseless electrical activity or asystole).
